Green light for Covaxin likely in 4-6 weeks: WHO expert
A WHO pre-qualification, or Emergency Use Listing, is necessary for a vaccine manufacturer to supply vaccines to global entities such as COVAX or even internationally.
Share Via Email
| A+A A-
A health worker shows the vials fo Covaxin dose, at a vaccination centre in Kolkata. (Photo | PTI)
Express News Service
BENGALURU: The World Health Organisation (WHO) is likely to take a decision on including Bharat Biotech’s Covaxin in its list of vaccines approved for emergency use, in four to six weeks, the world body’s Chief Scientist Dr Soumya Swaminathan has said. A WHO pre-qualification, or Emergency Use Listing, is necessary for a vaccine manufacturer to supply vaccines to global entities such as COVAX or even internationally.